Octaplex Dosing App

Octaplex App

IPhone / Mobile Compatible

Viewport Meta

Domain Not Resolving

SSL by Default

Apple Mobile Web Clips Icon

Google Font API

HSTS

Amazon

WordPress

nginx

Network Platform Team Owner

Adam America

Owner

Jakob Karner

Melissa Rogers

Michael Holloway

Assistant R&D Board Member/Paralegal R&D/Vendor Manager R&D

Sabine Vogl-Feischl

Vulnerability Management Service Owner

Thiago Maia

Vice President - Head of Corporate Communications

Gavin Montgomery

Sales and Support

Jesse Kiss

SVP National Accounts / Market Access

Neil Herson

Director of Operations

Abbey Chacko

Wolfgang Marguerre

Co-Founder, Chairman & CEO

Marc Rechsteiner

Global Senior Director Corporate Operational & Process Excellence

Rada Brujic

Corporate Logistic Buyer

Pharmaceutical Companies With More Than 500 Employees

University of Heidelberg Alumni Founded Companies

Manufacturing Companies With More Than $500 in Revenue

Europe Companies With More Than $1B in Revenue

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. Since its establishment in 1983 the company has been dedicated to improving the lives of patients. 

Octapharma was founded in 1983 on the fundamental principle of improving the lives of patients. Since then we have remained focused on our collective responsibility for the trust instilled in us by physicians and patients worldwide. In 2012, the Octapharma Board identified the core strategic pillars which will lead to the achievement of the organization’s ambitious long term goals.

Lachen

Schwyz

Switzerland

Europe

Octapharma

Federman & Sherwood Investigates Octapharma Plasma, Inc. for Data Breach

Octapharma's continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ...

Octapharma USA Appoints Biopharma Industry Veteran Kelly Hearn Vice President of Commercial Marketing & ...

Intravenous Immunoglobulin Market Expected to Grow at 7.0% CAGR, Reaching USD 24.4 Billion by 2032

Intravenous Immunoglobulin Market Anticipated Worth USD 24.13 Billion by 2032, with a Remarkable 7.50% CAGR...

Plasma Fractionation Market Future Business Opportunities 2024-2031 | CSL Ltd., Octapharma AG, Grifols S.A.

Patients Sue NC Plasma Donation Co. Over Data Breach

Octapharma USA: FDA Grants Orphan Drug Exclusivity to wilate®, the First VWF Concentrate for Prophylaxis in All ...

Propionic Acidemia Treatment Market to See Massive Growth by 2030 | CSL Behring, Octapharma AG, Sanquin ...

Octopharma Plasma's US operations shut down due to suspected ransomware attack

United States

North America

Austria

Italy

France

India

Asia

HTML5

Google Fonts

Google Tag Manager

Bootstrap

jQuery

Google Analytics

Symantec Email Security.Cloud

Apache Server

Google Maps API

Adobe Flash

Octapharma is a global healthcare company specializing in the development and manufacturing of high-quality human protein-based medicines for haematology, immunotherapy, and critical care. The company is family-owned and headquartered in Lachen, Switzerland.

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

company_structure

crunchbase_trigger

crunchbase_profile

li_profile

translate_crunchbase_fundingrounds

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general	Mar 9, 2024 2:26 AM	106dab8c
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 9, 2024 2:26 AM	e887baf3
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
crunchbase trigger	general	Oct 30, 2024 1:02 PM	e69ab0d9
crunchbase profile	general	Oct 30, 2024 1:38 PM	ae015235
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	fb524cc2
peers	general
news basic	general	Mar 9, 2024 2:26 AM	b161c9c9
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
company structure	company_analysis
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

OCTA

COM:OCTAPHARMA

Octapharma